Naproxen oral anti-inflammatory drug Pharmaceutical Raw Materials white raw

Naproxen oral anti-inflammatory drug white raw Naproxen powder factory supply 22204-53-1

Naproxen Basic information:

Name: Naproxen
: 22204-53-1
MF: C14H14O3
MW: 230.26
Standard: USP
Purity: Pharmaceutical grade 99%
Appearance: white powder
chemical properties: White crystal or crystalline powder. Melting point 155.3 ℃. Soluble in acetone, soluble in methanol, ethanol, acetic acid, insoluble in benzene, practically insoluble in water. In e of light,it is color-graded, odorless, tasteless.
Packing: 25KG / Fiber drum

Naproxen Description:

Naproxen has anti-inflammatory, antipyretic and analgesic effects and is a PG synthetase inhibitor. For rheumatoid arthritis and osteoarthritis effect, similar to aspirin. For anemia, gastrointestinal diseases or other reasons can not tolerate aspirin, indomethacin and other anti-inflammatory analgesic patients, this product can be satisfied with the results, while inhibiting the role of platelets smaller.

Indications:

For rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout, sports systems (such as joints, muscles and tendons) chronic degenerative diseases and mild to moderate pain such as dysmenorrhea.

Adverse reactions:

Mainly gastrointestinal tract mild and temporary discomfort. Manifested as nausea, vomiting, dyspepsia and constipation; insomnia or drowsiness, headache, dizziness, tinnitus, itching, rashes, angioneurotic edema, visual impairment, prolonged bleeding, agranulocytosis, gastrointestinal bleeding, dyspnea, Liver and kidney damage and mental depression.

Precautions:

Prohibit the use of aspirin allergy, accompanied by history of peptic ulcer or peptic ulcer with caution. Because other non-steroidal anti-inflammatory drugs can make fetal ductus arteriosus early closure, but also inhibit prostaglandin synthesis lead to prolonged labor or labor, so unless otherwise, pregnant women should not be used. This product is secreted into the milk concentration equivalent to 1% of blood concentration, lactating women should not be applied. Long-term medication should be regularly liver and kidney function, blood and eye examination